These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36414219)

  • 1. Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
    Meroni PL; Croci S; Lonati PA; Pregnolato F; Spaggiari L; Besutti G; Bonacini M; Ferrigno I; Rossi A; Hetland G; Hollan I; Cugno M; Tedesco F; Borghi MO; Salvarani C
    Autoimmun Rev; 2023 Jan; 22(1):103232. PubMed ID: 36414219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.
    Valenti L; Griffini S; Lamorte G; Grovetti E; Uceda Renteria SC; Malvestiti F; Scudeller L; Bandera A; Peyvandi F; Prati D; Meroni P; Cugno M
    J Autoimmun; 2021 Feb; 117():102595. PubMed ID: 33453462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Plasma 25(OH)D
    Alabdullatif W; Almnaizel A; Alhijji A; Alshathri A; Albarrag A; Bindayel I
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation and endothelial perturbation parallel COVID-19 severity and activity.
    Cugno M; Meroni PL; Gualtierotti R; Griffini S; Grovetti E; Torri A; Lonati P; Grossi C; Borghi MO; Novembrino C; Boscolo M; Uceda Renteria SC; Valenti L; Lamorte G; Manunta M; Prati D; Pesenti A; Blasi F; Costantino G; Gori A; Bandera A; Tedesco F; Peyvandi F
    J Autoimmun; 2021 Jan; 116():102560. PubMed ID: 33139116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.
    Rajamanickam A; Venkataraman A; Kumar NP; Sasidaran R; Pandiarajan AN; Selvaraj N; Mittal R; Gowshika K; Putlibai S; Lakshan Raj S; Ramanan PV; Babu S
    BMC Pediatr; 2023 Apr; 23(1):156. PubMed ID: 37013538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
    Smail SW; Babaei E; Amin K; Abdulahad WH
    Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
    Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
    Front Immunol; 2021; 12():716361. PubMed ID: 34491250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and biochemical biomarker alterations among SARS-COV-2 patients with varying disease phenotypes in Uganda.
    Kato CD; Nsubuga J; Niyonzima N; Kitibwa A; Matovu E; Othieno E; Ssebugere P; Tumwine AA; Namayanja M
    BMC Infect Dis; 2023 Dec; 23(1):857. PubMed ID: 38057707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
    Vachino G; Gelfand JA; Atkins MB; Tamerius JD; Demchak P; Mier JW
    Blood; 1991 Nov; 78(10):2505-13. PubMed ID: 1824247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
    Sinkovits G; Mező B; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Front Immunol; 2021; 12():663187. PubMed ID: 33841446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biochemical short-term effects of hyperbaric oxygen therapy on SARS-Cov-2+ hospitalized patients with hypoxemic respiratory failure.
    Keller GA; Colaianni I; Coria J; Di Girolamo G; Miranda S
    Respir Med; 2023 Apr; 209():107155. PubMed ID: 36796547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.
    Deng F; Zhang L; Lyu L; Lu Z; Gao D; Ma X; Guo Y; Wang R; Gong S; Jiang W
    Med Clin (Engl Ed); 2021 Apr; 156(7):324-331. PubMed ID: 33824908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated NET, Calprotectin, and Neopterin Levels Discriminate between Disease Activity in COVID-19, as Evidenced by Need for Hospitalization among Patients in Northern Italy.
    Hetland G; Fagerhol MK; Mirlashari MR; Nissen-Meyer LSH; Croci S; Lonati PA; Bonacini M; Salvarani C; Marvisi C; Bodio C; Muratore F; Borghi MO; Meroni PL
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombopoietin participates in platelet activation in COVID-19 patients.
    Lupia E; Capuano M; Vizio B; Schiavello M; Bosco O; Gelardi M; Favale E; Pivetta E; Morello F; Husain S; Keshavjee S; Del Sorbo L; Montrucchio G
    EBioMedicine; 2022 Nov; 85():104305. PubMed ID: 36242922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19.
    Satış H; Özger HS; Aysert Yıldız P; Hızel K; Gulbahar Ö; Erbaş G; Aygencel G; Guzel Tunccan O; Öztürk MA; Dizbay M; Tufan A
    Cytokine; 2021 Jan; 137():155302. PubMed ID: 33002740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19.
    Ruggeri T; De Wit Y; Schärz N; van Mierlo G; Angelillo-Scherrer A; Brodard J; Schefold JC; Hirzel C; Jongerius I; Zeerleder S
    J Innate Immun; 2023; 15(1):850-864. PubMed ID: 37939687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.